Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
HCPCS Code

HCPCS code S0012 – Sumatriptan 6mg injection billing guide


Code Definition

S0012 is the HCPCS Level II code for butorphanol tartrate, nasal spray, 25 mg. One unit equals 25 mg, the contents of one 2.5 mL bottle of the 10 mg/mL spray.

S0012 is a temporary national S-code for non-Medicare payers, so Medicare does not pay it. Butorphanol is a Schedule IV opioid agonist-antagonist, and each payer that accepts the code sets its own coverage, quantity and authorization rules.

Level
Level II
Category
S0012-S9999 Temporary national codes (non-Medicare)
Code range
S0012-S0197 Non-Medicare drug codes
Billable
No
Code also known as
Stadol NS, butorphanol nasal spray
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

HCPCS Code S0012 describes butorphanol tartrate nasal spray, 25 mg, which is one 2.5 mL bottle of the 10 mg/mL product.

S0012 is a temporary national S-code for non-Medicare payers, so Medicare does not pay it and each other payer sets its own rules.

Butorphanol is a Schedule IV mixed opioid agonist-antagonist, and its label indication is pain severe enough to need an opioid.

Bill one unit per 25 mg bottle supplied, never one unit per 1 mg spray.

Most S0012 denials trace back to billing Medicare, a missing NDC, a missing authorization, or a unit count built on sprays.

HCPCS Code S0012: Definition and clinical use

HCPCS Code S0012 is the Level II code for butorphanol tartrate, nasal spray, 25 mg. AAPC lists it in the non-Medicare drug code group, S0012 through S0197. Private insurers and Medicaid programs use S-codes, which the CMS HCPCS workgroup maintains. Medicare does not pay them.

Butorphanol is a synthetic opioid with mixed agonist-antagonist activity. The nasal spray was first sold under the brand name Stadol NS. Today, practices and pharmacies mostly supply generic butorphanol tartrate nasal spray USP.

The FDA-approved label lists one indication. That is pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. The label’s clinical trials covered postoperative pain, musculoskeletal pain and migraine headache pain.

The patient self-administers the spray, one metered spray into one nostril at a time. That detail shapes billing more than the drug itself, as the coverage sections below show.

Official descriptor and drug details

The table below summarizes what billers need before they submit a claim for HCPCS Code S0012.

FieldDetail
HCPCS codeS0012
Official descriptorButorphanol tartrate, nasal spray, 25 mg
Code rangeS0012-S9999 Temporary national codes (non-Medicare)
Code groupS0012-S0197 Non-Medicare drug codes
DrugButorphanol tartrate (brand name Stadol NS; generic nasal spray USP)
Strength and pack10 mg/mL solution in a 2.5 mL bottle, which holds 25 mg
Dose per sprayAbout 1 mg of butorphanol tartrate after the pump is primed
Drug classOpioid agonist-antagonist analgesic
DEA scheduleSchedule IV controlled substance
Medicare statusNot payable by Medicare

The 25 mg in the descriptor matches one full bottle. The label says a primed bottle delivers about 14 to 15 doses. With repriming between uses, it delivers about 8 to 10 doses.

What HCPCS Code S0012 covers and what it does not

S0012 reports the butorphanol nasal spray product itself, counted in 25 mg units. Outside that scope, a different code applies.

Reported with S0012: butorphanol tartrate nasal spray supplied to the patient, when the payer accepts S-codes for drugs.

Not reported with S0012:

  • Butorphanol tartrate injection, which has its own J-code, J0595, billed per 1 mg
  • Sumatriptan succinate 6 mg injection, which is J3030, not S0012
  • Other opioid nasal products, such as naloxone or nalbuphine, which are different drugs
  • A pharmacy-benefit prescription claim, which runs on the NDC rather than a HCPCS code
  • An injection administration service, because the patient sprays the dose and no injection takes place

Correct units of service for S0012

One unit of HCPCS Code S0012 equals 25 mg of butorphanol tartrate, which is one 2.5 mL bottle. Count units by bottles supplied, not by sprays. A single 1 mg spray is not one unit.

The most common unit error is billing the number of doses. A bottle that delivers 14 sprays is still one unit. Checking each claim line against the descriptor is part of submitting a clean claim.

The diagram below shows how one unit is built from the label figures, and why the route, not the drug, decides the code.

Diagram: 10 mg/mL times 2.5 mL equals 25 mg, one bottle, which is 1 unit of HCPCS S0012.
A bottle stays one unit whether it yields 8 or 15 doses, while the injection switches to J0595 per 1 mg. Figures from the FDA label and the HCPCS descriptors.
ScenarioUnits to billNotes
One bottle supplied1Standard presentation, 25 mg in 2.5 mL
Two bottles supplied2Check the payer’s quantity limit for opioids first
Several sprays from one bottle1Sprays are doses, not units
Butorphanol injection given in the officeNot S0012Use J0595, billed per 1 mg

Label dosing also explains why quantity limits matter. The usual first dose is 1 mg, one spray in one nostril. If pain relief is not adequate within 60 to 90 minutes, the label allows a second 1 mg dose. The sequence may repeat in 3 to 4 hours as required.

Supported ICD-10 diagnosis codes for S0012

The diagnosis has to support opioid-level pain, because that is the label indication. Payers that cover S0012 usually expect the code that names the cause of the pain. Where the encounter is about pain control, a pain code from G89 or R52 may apply.

ICD-10-CM codeDescriptionNotes
G89.11Acute pain due to traumaAcute pain after an injury
G89.18Other acute postprocedural painPain after surgery or a procedure
G89.29Other chronic painChronic pain without a more specific code
G89.4Chronic pain syndromeUse only when the record documents the syndrome
M54.50Low back pain, unspecifiedExample of a site-specific musculoskeletal code
R52Pain, unspecifiedLeast specific; use a more precise code when the chart supports it

These codes are examples, not a coverage list. Each payer’s policy decides which diagnoses it accepts for an opioid nasal spray. Confirm current code status in the ICD-10-CM tabular list before you submit.

Medicare coverage for HCPCS Code S0012

Traditional Medicare does not pay HCPCS Code S0012. Private insurers and Medicaid programs use S-codes, which the CMS HCPCS workgroup maintains. The HCPCS file marks them not payable by Medicare, so a claim to Medicare Part B with S0012 returns a denial.

A self-administered nasal spray also falls outside the usual Part B drug benefit. Two other routes can apply to Medicare patients:

  • Medicare Advantage (Part C): individual plans may accept S-codes under their own policies. Verify coverage and authorization rules with each plan.
  • Medicare Part D: a Part D plan may cover butorphanol nasal spray as a pharmacy claim, subject to its formulary. That claim runs through the pharmacy, not on a CMS-1500 form with S0012.

Before you supply the spray to a Medicare patient, run an eligibility check. It tells you whether the patient has an Advantage plan and what that plan accepts.

Medicaid and commercial payer coverage

State Medicaid programs and commercial plans decide for themselves whether to accept S0012. Rules for opioids vary widely by state and by plan. Insurance eligibility verification at scheduling shows which of those rules apply before the patient arrives.

Requirements to check with each payer:

  • NDC on the claim line: many Medicaid programs require the 11-digit National Drug Code on drug lines, with the N4 qualifier. Some commercial plans ask for it too.
  • Opioid quantity limits: plans often cap how many bottles a patient can receive in a set period. A higher quantity usually needs an exception request.
  • Prior authorization: some plans require authorization for opioid analgesics, especially for new or long-term use.
  • Code preference: some payers want a pharmacy claim for a self-administered drug instead of a medical claim with S0012. Ask which route the plan expects.

Payer policies on opioids change often. Check the current policy before each authorization request rather than relying on last year’s answer.

Prior authorization requirements for S0012

Whether S0012 needs prior authorization depends on the payer. No blanket rule applies. These triggers commonly start an authorization request for an opioid analgesic:

  • The quantity exceeds the plan’s limit for the period
  • The patient is opioid-naive, or the request starts long-term opioid therapy
  • The patient also takes a benzodiazepine or another central nervous system depressant
  • The record does not show that non-opioid treatments were tried or were inadequate
  • The plan lists butorphanol nasal spray as non-preferred

When authorization is required, the package usually includes the diagnosis and its ICD-10 code. It also covers prior treatments and their results, the prescriber’s rationale, and the requested quantity. Keep the approval number on file and report it on the claim.

Pro Tip

Confirm authorization and the quantity limit before the patient leaves with the spray. A missing authorization on an opioid claim takes far longer to fix after the fact than a call to the plan beforehand.

Documentation requirements for S0012 claims

Solid documentation underpins billing compliance requirements. Butorphanol is a Schedule IV controlled substance, so the record has to satisfy both the payer and controlled-substance rules.

  • Prescriber order: a signed order naming the drug, strength, dose, directions and quantity
  • Diagnosis: an ICD-10-CM code supported by the encounter note, with the pain assessment behind it
  • Supply record: date, quantity in bottles, lot number and expiry, and who supplied the spray
  • NDC: the 11-digit NDC with the N4 qualifier when the payer requires it
  • Authorization number: reported on the claim when the plan required approval
  • Patient counseling: a note that the patient received the label’s safety information on use, storage and disposal

Each item above maps to a denial risk. A missing NDC draws a Medicaid rejection, and a missing authorization number holds a commercial claim.

Several codes get confused with HCPCS Code S0012 during claim preparation. The comparison below shows when each one applies.

CodeDrug / servicePayer useKey distinction
S0012Butorphanol tartrate, nasal spray, 25 mgCommercial, MedicaidSelf-administered nasal spray; not payable by Medicare
J0595Injection, butorphanol tartrate, 1 mgMedicare, Medicaid, commercialSame drug as an injection, billed per 1 mg
J3030Injection, sumatriptan succinate, 6 mgMedicare, Medicaid, commercialA triptan for migraine, not butorphanol
S0014Tacrine hydrochloride, 10 mgCommercial, MedicaidAnother non-Medicare drug code in the same S0012-S0197 group

The J0595 versus S0012 question causes the most mix-ups, because the drug is the same. The route decides the code: injection is J0595 per 1 mg, nasal spray is S0012 per 25 mg bottle.

Common claim denials for HCPCS Code S0012 and how to resolve them

Most S0012 denials are predictable. The table below maps common scenarios to their claim adjustment reason codes (CARC) and the fix. A broader guide to medical billing denial codes explains the CARC and RARC pairs behind them. Systematic denial management workflows catch these before they turn into write-offs.

Denial scenarioCARCCorrective action
Billed to traditional MedicareCO-96Do not bill S0012 to Medicare; check for an Advantage plan or a Part D pharmacy route
Missing or invalid NDCCO-16 with RARC MA130Add the 11-digit NDC with the N4 qualifier and match it to the bottle supplied
Units billed per sprayCO-151 or CO-16Rebill one unit per 25 mg bottle
Quantity over the plan limitCO-151Request a quantity exception with clinical documentation before you resubmit
Unsupported diagnosis codeCO-11Report the documented cause of the pain, or a supported pain code
Authorization missing or expiredCO-197 or CO-15Ask about retro-authorization, then add the approval number to the claim
Wrong code for the routeCO-16Use J0595 for butorphanol injection, and S0012 only for the nasal spray

How Pabau keeps S0012 claims accurate

S0012 claims fail when the supply record, the authorization and the claim live in different places. Someone retypes the NDC or the quantity, and the error reaches the payer. Pabau, a practice management platform, keeps those details on one patient record.

Pabau’s claims management software pulls what is already on the record into a pre-filled claim. In the US it submits through Claim.MD, runs eligibility checks, and tracks remittances. Stock in Pabau carries a batch number and expiry date, recorded against the patient and the appointment.

Pabau’s prescription management keeps the prescriber’s order in the same record. Your billers review a claim built from the chart instead of rebuilding it by hand.

Pabau remittance screen matching insurer payments to patient invoices, with statuses
Pabau’s remittance view matches each insurer payment to its invoice. A short-paid or reissued drug line shows up before it ages in accounts receivable.

Keep drug code claims tied to the chart

Pabau pulls the order, the lot and the patient’s coverage from one record into a pre-filled claim. Your team checks eligibility before the visit and tracks every remittance after it.

Pabau claims management dashboard

Conclusion

Treat S0012 as a payer question first and a coding question second. The descriptor is simple: one unit is one 25 mg bottle of butorphanol nasal spray. The hard part is knowing whether this patient’s plan accepts the code at all.

Settle that before the spray leaves the practice. Check the plan, the quantity limit and the authorization, and keep J0595 for the injection. Do that, and S0012 becomes a routine line rather than a recurring denial.

Book a demo to see how Pabau keeps drug code claims accurate from order to remittance.

Continue your research

Continue your research

Billing butorphanol as an injection instead? HCPCS Code J0595 covers the per-1 mg injection code for the same drug.

Need a denial resolution framework for drug codes? Denial codes in medical billing explains common CARC and RARC combinations and how to resolve them.

Want to understand the clearinghouse role in HCPCS claims? Medical claims clearinghouse covers how claims are routed, scrubbed, and adjudicated between providers and payers.

Building a revenue cycle checklist for drug billing? What is revenue cycle management walks through the process from eligibility to payment posting.

Frequently asked questions

What does HCPCS code S0012 cover?

HCPCS Code S0012 covers butorphanol tartrate nasal spray, 25 mg. One unit is one 2.5 mL bottle of the 10 mg/mL spray. Butorphanol injection is a different code, J0595, and sumatriptan injection is J3030.

Is S0012 covered by Medicare?

No. S0012 is a temporary national S-code for non-Medicare payers, and Medicare does not pay it. A Medicare Advantage plan may accept it under its own policy. A Part D plan may cover the spray as a pharmacy claim, subject to its formulary.

What is the correct unit of service for S0012?

One unit equals 25 mg, which is one full bottle. Count units by bottles supplied, never by sprays. Each spray delivers about 1 mg, so billing one unit per spray overstates the quantity.

Does S0012 require prior authorization?

It depends on the payer. Butorphanol is a Schedule IV opioid, so many plans apply quantity limits or prior authorization. Common triggers include quantities over the limit, new long-term opioid therapy, and a non-preferred formulary status.

Does S0012 Medicaid coverage vary by state?

Yes. Each state Medicaid program decides whether it accepts S0012 and sets its own authorization and quantity rules. Many states also require the 11-digit NDC on drug lines. Check the state’s billing guidance before you submit.

Avatar photo
Despina Petrushevska
Content Writer

Despina Petrushevska is a content writer covering aesthetics, dermatology, and clinic operations, known for making detailed clinical concepts clear and engaging. Outside of work, she enjoys photography, weekend getaways, and finding inspiration in everyday experiences.
×